We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Italian Firm Acquires Fast Melt Technology

By Biotechdaily staff writers
Posted on 07 Feb 2003
The worldwide rights to a new pharmaceutical fast melt technology and manufacturing process have been acquired by Eurand (Milan, Italy) under an agreement with Kyowa Hakko Kogyo Co., Ltd. More...
(Tokyo, Japan).

The new fast melt technology will allow patients to take their medications anytime, anywhere without chewing or the need for water. The technology produces an orally administered fast-dissolving dosage form and is broadly applicable, since it can be used with both soluble and insoluble products. The tablet is produced using a proprietary system that utilizes 10-30 times less hydrophobic lubricant than conventional tablet production. The resulting tablet is both hard and durable but does not impede liquid entry upon contact with saliva. In addition, the tablet does not contain water-insensitive cohesive bonds between particles to hinder disintegration. Eurand intends to market the products in combination with Microcaps, the company's taste-masking technology.

"This technology is different from the competition in that while it offers a first class fast melt tablet in terms of speed of disintegration, it is both easy to produce and more robust than other fast melt tablets,” noted Gearoid Faherty, CEO of Eurand.





Related Links:
Eurand
Kyowa

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.